Check our
Open Access Repository.
2022
18 publication(s):Note: when necessary, only the first 15 authors are displayed.International refereed journal articles
- 1 -
- Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group
- C. Bonnet, J. Dupuis, H. Tilly, T. Lamy, C. Fruchart, S. Le Gouill, C. Thieblemont, F. Morschhauser, O. Casasnovas, K. Bouabdallah, H. Ghesquieres, E. van den Neste, M. Andre, G. Cartron, G. Salles et al.
- Cancers, MDPI, 2022, 14 (7), pp.1761.
- DOI : https://doi.org/10.3390/cancers14071761
- Pubmed : 35406532

-

- 2 -
- From B-cell self-control to therapeutic approaches, could B-cell intrinsic strategies temper IgE responses and IgE memory?
- M. Cogné, Z. Dalloul, O. Dézé, M. Le Goff, S. Thomas, M. Cahen, N. Ueda, B. Laffleur
- Du self-control lymphocytaire B aux abords thérapeutiques, quelles voies « B-intrinsèques » pour tempérer les réponses et la mémoire IgE ?. Revue francaise d'allergologie, Elsevier, 2022,
- DOI : https://doi.org/10.1016/j.reval.2021.10.012

-

- 3 -
- Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
- D. Costes-Tertrais, T. Hueso, T. Gastinne, C. Thieblemont, L. Oberic, K. Bouabdallah, S. Garciaz, E. Tchernonog, C. Dartigeas, V. Ribrag, P. Fogarty, R.-O. Casasnovas, R. Houot, C. Delette, S. Malak et al.
- Bone Marrow Transplantation, Nature Publishing Group, 2022,
- DOI : https://doi.org/10.1038/s41409-022-01596-8
- Pubmed : 35149851
-

- 4 -
- Toward a Better Classification System for NK-LGL Disorders
- G. Drillet, C. Pastoret, A. Moignet, T. Lamy, T. Marchand
- Frontiers in Oncology, Frontiers, 2022, 12, pp.821382.
- DOI : https://doi.org/10.3389/fonc.2022.821382
- Pubmed : 35178350

-

- 5 -
- Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
- D. Farge, S. Loisel, M. Resche-Rigon, P. Lansiaux, I. Colmegna, D. Langlais, C. Charles, G. Pugnet, A. T. J. Maria, E. Chatelus, T. Martin, E. Hachulla, V. D. Kheav, N. C. Lambert, H. C. Wang et al.
- The Lancet Rheumatology, Elsevier, 2022, 4 (2), pp.E91-E104.
- DOI : https://doi.org/10.1016/S2665-9913(21)00326-X

-

- 6 -
- Molecular networking for drug toxicities studies: The case of hydroxychloroquine in covid-19 patients
- P.-J. Ferron, B. Le Daré, J. Bronsard, C. Steichen, E. Babina, R. Pelletier, T. Hauet, I. Morel, K. Tarte, F. Reizine, B. Clément, B. Fromenty, T. Gicquel
- International Journal of Molecular Sciences, MDPI, 2022, 23 (1), pp.82.
- DOI : https://doi.org/10.3390/ijms23010082
- Pubmed : 35008505

-

- 7 -
- Pivotal role of PIM2 kinase in plasmablast generation and plasma cell survival, opening new treatment options in myeloma
- M. Haas, G. Caron, F. Chatonnet, S. Manenti, E. Alaterre, J. Devin, C. Delaloy, G. Bertolin, R. Viel, A. Pignarre, F. Llamas Gutierrez, A. Marchalot, O. Decaux, K. Tarte, L. Delpy et al.
- Blood, American Society of Hematology, 2022,
- DOI : https://doi.org/10.1182/blood.2021014011
- Pubmed : 35108359

-

- 8 -
- Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
- R. Houot, V. Poeschel, B. Altmann, S. Angel, L. Thurner, T. Illmer, M. Andre, M. Dreyling, H. Maisonneuve, H. Tilly, S. Mayer, O. Casasnovas, S. Le Gouill, F. Offner, G. Cartron et al.
- Hemasphere, 2022, 6 (2),
- DOI : https://doi.org/10.1097/HS9.0000000000000672
- Pubmed : 35028526

-

- 9 -
- RNA-based immunoglobulin repertoire sequencing is a new tool for the management of monoclonal gammopathy of renal (kidney) significance
- V. Javaugue, V. Pascal, S. Bender, S. Nasraddine, M. Dargelos, M. Alizadeh, A. Saintamand, M. Filloux, P. Derouault, S. Bouyer, E. Desport, A. Jaccard, F. Bridoux, M. Cogné, C. Sirac et al.
- Kidney International, Nature Publishing Group, 2022, 101 (2), pp.331-337.
- DOI : https://doi.org/10.1016/j.kint.2021.10.017
- Pubmed : 34767830

-

- 10 -
- Disease-specific outcomes after chimeric antigen receptor T-cell therapy
- J. Lemoine, S. Vic, R. Houot
- European Journal of Cancer, Elsevier, 2022, 160, pp.235-242.
- DOI : https://doi.org/10.1016/j.ejca.2021.10.022
- Pubmed : 34865943
-
